Champions Oncology (CSBR) EBT Growth (5y) (2015 - 2026)
Champions Oncology (CSBR) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.04% |
| Jan 31, 2026 | -17.54% |
| Oct 31, 2025 | 73.97% |
| Jul 31, 2025 | -48.15% |
| Apr 30, 2025 | 1.07% |
| Jan 31, 2025 | 60.90% |
| Oct 31, 2024 | 18.37% |
| Jul 31, 2024 | 32.80% |
| Apr 30, 2024 | -4.84% |
| Jan 31, 2024 | -46.84% |
| Oct 31, 2023 | -57.48% |
| Jul 31, 2023 | -48.68% |
| Apr 30, 2023 | -32.72% |
| Jan 31, 2023 | -100.90% |
| Oct 31, 2022 | 52.53% |
| Jul 31, 2022 | 14.73% |
| Apr 30, 2022 | 32.18% |
| Jan 31, 2022 | 20.74% |
| Oct 31, 2021 | 20.76% |
| Jul 31, 2021 | 42.58% |